The Filing Desk

Envoy Medical vs Pulse Biosciences

Envoy Medical COCH · Pulse Biosciences PLSE · Health Care Equipment

Pulse Biosciences reported revenue of $0 million in fiscal 2025, 1.5 times Envoy Medical's $0 million in fiscal 2025. Envoy Medical had an operating margin of -9240.7%, against -21982.6% at Pulse Biosciences. Free cash flow was −$18 million at Envoy Medical and −$54 million at Pulse Biosciences.

Side by side

Envoy MedicalPulse Biosciences
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$0M$0M
Revenue growth7.1%—
Revenue growth a year, last 5 years——
Gross margin−262.7%−54.0%
Operating margin−9,240.7%−21,982.6%
Net margin−9,857.3%−20,794.6%
Free cash flow−$18M−$54M
Free cash flow margin−7,626.6%−15,553.4%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$2M$0M
Change in diluted share count23.8%15.4%
Last close$6.70$44.41
P/E at the last close——
Insider trades, last 12 months—bought $13.5 million, sold $2.9 million
Piotroski F-score—3 of 8
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Envoy MedicalPulse Biosciences
Operating margin
Percent of revenue
Envoy MedicalPulse Biosciences
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Envoy MedicalPulse Biosciences

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Envoy Medical and Pulse Biosciences pages.